Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry
Launched by MAYO CLINIC · Sep 14, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Tapestry patients who have received genetic results, regardless of positive or negative testing results.
- • Age of 18 and older.
- • Patients with an established Mayo Clinic provider prior to their enrollment in Tapestry.
- Exclusion Criteria:
- • Individuals less than 18 years old.
- • Patients without capacity to consent (i.e., needing legal authorized representatives).
- • Prisoners.
- • Subjects eligible for chart review, without a Minnesota Research Authorization on record.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Scottsdale, Arizona, United States
Rochester, New York, United States
Patients applied
Trial Officials
Niloy Jewel Samadder, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials